Cibc Private Wealth Group, LLC Jounce Therapeutics, Inc. Transaction History

Cibc Private Wealth Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 21, 2023	BUY	$0.9 - $1.85 $27,000 - $55,500	30,000 New	30,000 $55,000
Q1 2023 May 11, 2023	SELL	$0.9 - $1.85 $9,382 - $19,286	-10,425 Reduced 25.79%	30,000 $55,000
Q4 2022 Jun 01, 2023	BUY	$0.64 - $1.99 $6,672 - $20,745	10,425 Added 34.75%	40,425 $44,000
Q4 2022 Feb 13, 2023	BUY	$0.64 - $1.99 $12,800 - $39,800	20,000 Added 97.92%	40,425 $44,000
Q3 2022 Nov 14, 2022	BUY	$2.73 - $4.92 $55,760 - $100,491	20,425 New	20,425 $48,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.